With clinical success on a personalized mRNA vaccine for melanoma, experts are hoping for a more stable future for the ...
An AstraZeneca heart disease trial failure has put Alnylam under pressure. It's mounting a defense of its medicines.
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. When Baby KJ was introduced to the world ...
Juul has received FDA clearance to sell an updated version of its e-cigarette, which includes an optional age-verification ...
The FDA approved a life-extending treatment for advanced pancreatic cancer from Revolution Medicines that is the first to ...
A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart health.
RFK Jr.'s vaccine questions in Samoa, former Stanford president rebuts fraud allegations, and more health news from Morning ...
A scramble to prepare for massive federal cuts across the health care system is hitting rural states like Maine particularly ...
Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news ...
The Trump administration did not overhaul the childhood vaccine schedule or flip the food pyramid until Heidi Overton, deputy ...
Oxford researchers call shingles shot first vaccine protecting both heart and brain. Lower heart disease risk follows study ...
WASHINGTON — After Pennsylvania health authorities announced that two unvaccinated people had died from measles-associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results